| Title : Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease - Baakman_2021_Br.J.Clin.Pharmacol__ |
| Author(s) : Baakman AC , Gavan C , van Doeselaar L , de Kam M , Broekhuizen K , Bajenaru O , Camps L , Swart EL , Kalisvaart K , Schoonenboom N , Lemstra E , Scheltens P , Cohen A , van Gerven J , Groeneveld GJ |
| Ref : British Journal of Clinical Pharmacology , : , 2021 |
| Abstract : |
| PubMedSearch : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedID: 34964149 |
| Title : Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease - Baakman_2021_Br.J.Clin.Pharmacol__ |
| Author(s) : Baakman AC , Gavan C , van Doeselaar L , de Kam M , Broekhuizen K , Bajenaru O , Camps L , Swart EL , Kalisvaart K , Schoonenboom N , Lemstra E , Scheltens P , Cohen A , van Gerven J , Groeneveld GJ |
| Ref : British Journal of Clinical Pharmacology , : , 2021 |
| Abstract : |
| PubMedSearch : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedID: 34964149 |
| Title : Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's Disease - Baakman_2021_Br.J.Clin.Pharmacol__ |
| Author(s) : Baakman AC , Gavan C , van Doeselaar L , de Kam M , Broekhuizen K , Bajenaru O , Camps L , Swart EL , Kalisvaart K , Schoonenboom N , Lemstra E , Scheltens P , Cohen A , van Gerven J , Groeneveld GJ |
| Ref : British Journal of Clinical Pharmacology , : , 2021 |
| Abstract : |
| PubMedSearch : Baakman_2021_Br.J.Clin.Pharmacol__ |
| PubMedID: 34964149 |
| Title : Available treatment options for the management of Lambert-Eaton myasthenic syndrome - Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| Author(s) : Verschuuren JJ , Wirtz PW , Titulaer MJ , Willems LN , van Gerven J |
| Ref : Expert Opin Pharmacother , 7 :1323 , 2006 |
| Abstract : |
| PubMedSearch : Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| PubMedID: 16805718 |
| Title : Available treatment options for the management of Lambert-Eaton myasthenic syndrome - Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| Author(s) : Verschuuren JJ , Wirtz PW , Titulaer MJ , Willems LN , van Gerven J |
| Ref : Expert Opin Pharmacother , 7 :1323 , 2006 |
| Abstract : |
| PubMedSearch : Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| PubMedID: 16805718 |
| Title : Available treatment options for the management of Lambert-Eaton myasthenic syndrome - Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| Author(s) : Verschuuren JJ , Wirtz PW , Titulaer MJ , Willems LN , van Gerven J |
| Ref : Expert Opin Pharmacother , 7 :1323 , 2006 |
| Abstract : |
| PubMedSearch : Verschuuren_2006_Expert.Opin.Pharmacother_7_1323 |
| PubMedID: 16805718 |